A Study of JSKN027 in Patients With Advanced Solid Tumors

Clinical trial NCT07391644 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07391644
Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumor

Start date: 2026-03-15
Primary completion: 2028-12-30
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.